MEDICAL DEVICES:

More than four years ago, the venture capitalist Olav Bergheim assembled a roundtable of leading cardiologist and electrophysiolgists to talk about their ideas for responding to two significant problems: heart failure and a rapid and irregular heart beat that puts patients at risk for stroke known as atrial fibrillation. The idea was to come up with alternatives to the current invasive and tissue-damaging approaches to treating these conditions, and instead address the ailments with the use of biopolymers.